Home
Home
/
Products
Products
/
Bioactive Compounds
Bioactive Compounds
/
JAK/STAT Signaling
JAK/STAT Signaling
/
JAK
JAK
JAK
Products (44)
Pacritinib
CAS No.:
937272-79-2
Delgocitinib
CAS No.:
1263774-59-9
Izencitinib
CAS No.:
2051918-33-1
(3S,4R)-Tofacitinib
CAS No.:
1092578-48-7
5-chloro-2-N-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-4-N-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine
CAS No.:
935666-88-9
Ivarmacitinib
CAS No.:
1445987-21-2
(2R,5S)-Ritlecitinib
CAS No.:
1792180-79-0
Atinvicitinib
CAS No.:
2169273-59-8
Filgotinib
CAS No.:
1206161-97-8
Baricitinib
CAS No.:
1187594-09-7
Itacitinib
CAS No.:
1334298-90-6
Gusacitinib
CAS No.:
1425381-60-7
Lestaurtinib
CAS No.:
111358-88-4
Ifidancitinib
CAS No.:
1236667-40-5
Mubritinib
CAS No.:
366017-09-6
N2-((1S)-1-(4-Fluorophenyl)ethyl)-4-(1-methyl-1H-pyrazol-4-yl)-N6-2-pyrazinyl-2,6-pyridinediamine
CAS No.:
1239358-86-1
VX 509
CAS No.:
944842-54-0
Gandotinib
CAS No.:
1229236-86-5
Lorpucitinib
CAS No.:
2230282-02-5
Povorcitinib Phosphate
CAS No.:
1637677-33-8
Products
CDMO Compounds
API & Candidates
Services
CDMO & Manufacturing
Custom Synthesis
Process Development
Lab To Pilot
Commercialization
Generic APIs
CRO
Preclinical
Pharmacology & Efficacy
DMPK & Bioanalysis
Toxicology & Safety
Disease Models
Technologies
High-Potent
Chiral Synthesis
Cloud Synthesis
Fermentation
Flow Chemistry
Biocatalysis
Support
Regulatory Support
Supply Chain Solutions
About
Perspectives
Contact